Current and future biomarkers in multiple sclerosis
J Yang, M Hamade, Q Wu, Q Wang, R Axtell… - International journal of …, 2022 - mdpi.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …
effective treatment for the progressive form of MS, partly due to insensitive readout for …
Molecular biomarkers in multiple sclerosis
T Ziemssen, K Akgün, W Brück - Journal of neuroinflammation, 2019 - Springer
Multiple sclerosis (MS) is an inflammatory-neurodegenerative disease of the central nervous
system presenting with significant inter-and intraindividual heterogeneity. However, the …
system presenting with significant inter-and intraindividual heterogeneity. However, the …
[HTML][HTML] New promising therapeutic avenues of curcumin in brain diseases
Curcumin, the dietary polyphenol isolated from Curcuma longa (turmeric), is commonly used
as an herb and spice worldwide. Because of its bio-pharmacological effects curcumin is also …
as an herb and spice worldwide. Because of its bio-pharmacological effects curcumin is also …
Immunology of multiple sclerosis
M Sospedra, R Martin - Annu. Rev. Immunol., 2005 - annualreviews.org
▪ Abstract Multiple sclerosis (MS) develops in young adults with a complex predisposing
genetic trait and probably requires an inciting environmental insult such as a viral infection …
genetic trait and probably requires an inciting environmental insult such as a viral infection …
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
There is a long history of research into body fluid biomarkers in neurodegenerative and
neuroinflammatory diseases. However, only a few biomarkers in CSF are being used in …
neuroinflammatory diseases. However, only a few biomarkers in CSF are being used in …
Digital biomarkers in multiple sclerosis
A Dillenseger, ML Weidemann, K Trentzsch, H Inojosa… - Brain sciences, 2021 - mdpi.com
For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …
the preservation of quality of life play a crucial role over the entire therapy period. In MS …
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
In 85% of young adults with multiple sclerosis (MS), onset is a subacute clinically isolated
syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the …
syndrome (CIS) of the optic nerves, brainstem, or spinal cord. Methods of assessing the …
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls
A Keller, P Leidinger, J Lange, A Borries, H Schroers… - PloS one, 2009 - journals.plos.org
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system, which is heterogenous with respect to clinical manifestations and response …
nervous system, which is heterogenous with respect to clinical manifestations and response …
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Background: Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the
cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of …
cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of …
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging
Purpose To investigate whether the variable forms of putative iron deposition seen with
susceptibility weighted imaging (SWI) will lead to a set of multiple sclerosis (MS) lesion …
susceptibility weighted imaging (SWI) will lead to a set of multiple sclerosis (MS) lesion …